diabetes mellitus (Beckett and Lewis, 1960; Mikkelsen, 1965) .
Studies of gouty patients have revealed a variable prevalence of diabetes mellitus. Umber (1914) reported a prevalence of 5-4 per cent. in 278 patients with gout, and other estimates range from 3 to 10 per cent. (Kuzell, Schaffarzick, Naugler, Koets, Mankle, Brown, and Champlin, 1955; Bartels, Balodimos, and Corn, 1960; Bendersky and Kreithen, 1962; Whitehouse and Cleary, 1966) . In addition, Weiss, Segaloff, and Moore (1957) found that 28 per cent. of 143 gouty patients had an abnormal oral glucose tolerance test using rigid criteria of a normal glucose tolerance test. Against these reports is the experience of Talbott in Buffalo who encountered only three patients with diabetes mellitus in his whole experience of patients with gout (Talbott, 1964) .
The present study was undertaken to investigate carbohydrate and insulin metabolism in patients with gout. Two groups of patients, one with normal body weight, and one matched for body weight with the gouty patients, served as controls. In a second approach to this problem, the effect of artificial elevation of serum uric acid values by ribonucleic acid (RNA) feeding on blood sugar and plasma insulin responses to an oral glucose load was studied. 101 -4 (range 70 to 120). Analgesic and any other therapy currently being taken had been discontinued one week before the study. All had been in-patients for at least one week before they were studied. None had ever received corticosteroid therapy.
In the second group of ten control patients the diagnosis of simple obesity had been established. They had been selected to match the gouty subjects for body weight. The method of patient selection in this study was as follows. Control patients were included in the study on the basis of their body weight without prior knowledge of whether or not they had glycosuria. The thirteen gouty patients were studied consecutively as they were admitted to hospital, irrespective of the presence of glycosuria or of body weight. All gouty patients who were seen for the first time at the out-patients department while this study was in progress were admitted for investigation.
Oral glucose tolerance tests were carried out in the fasting state using a 50 g. dose of glucose. Venous blood samples were taken in the fasting state, and at 30, 60, 90, and 120 min. after the dose of glucose. Blood sugar was estimated by the ferricyanide method on the Technicon Auto-Analyzer, and plasma insulin was measured by the method of Hales and Randle (1963) . Results of the insulin assay in this laboratory with regard to sensitivity and specificity have been presented elsewhere (Buchanan and McKiddie, 1967) .
Serum uric acid was measured by the Auto-Analyzer method N22.
In subjects given RNA the blood sugar and plasma insulin responses to the glucose load were measured immediately before and after 3 days of RNA feeding.
Tests of significance between means were calculated by Student's "t" test.
Results
Blood Sugar and Plasma Insulin Responses to an Oral Glucose Load (Table I ).-The measurement of fasting blood sugar (range 91-115 mg. per cent.) and fasting insulin (range 18 to 50,u units per ml.) on four successive days in six fasting patients gave a standard error of the mean of 1 * 6 and 2 8 per cent. respectively, indicating a good standard of reproducibility. (Table I) . The plasma insulin responses after oral glucose loading in the three groups are also shown in Table I . There was a very wide scatter of results in the gouty patients; one in particular showed an enormous response in plasma insulin level to the glucose load, from 160 ,uU per ml. he rose to 450 at 30 min. and then fell to 220 at 120 min. In this patient the blood sugar response was normal.
The mean plasma insulin response in normal weight controls were slightly lower than in patients with gout, but were only significantly lower (P < 0 025) at 90 minutes after glucose. In other words, the data suggest that gouty subjects have a slightly delayed fall-off in plasma insulin response after glucose. A similar delay was seen in the overweight controls, who did not differ from the lean controls in their fasting and 30 min. plasma insulin values, but had higher values at 60, 90, and 120 min. (Table II) .
Discussion
These results show that blood sugar values after oral glucose loading are significantly higher in patients with gout than in normal weight control subjects. Taking a blood sugar value greater than 120 mg. per cent. to be abnormal 120 minutes after the oral administration of 50 g. glucose, the data show that three of the 21 normal weight control patients and three of the thirteen gouty subjects were abnormal. In addition, patients with gout tended to have higher plasma insulin responses to glucose loading than normal weight controls, but such was the scatter in observations of plasma insulin levels that this tendency is significant only at the 90 min. stage after the glucose loading. One might conclude from these observations that there was an abnormality of carbohydrate and perhaps of insulin metabolism in patients with gout, but the findings in the obese controls who were weight-matched with One interpretation of these data which suggests itself is that there is an abnormality of carbohydrate and perhaps insulin metabolism in patients with gout and that this abnormality is a function of the obesity of these subjects rather than of the intrinsic abnormality associated with altered metabolism of purines causing hyperuricaemia. Tentative support for this conclusion comes from the finding that the blood sugar and plasma insulin responses to oral glucose are unaltered after the serum uric acid level has been raised by RNA feeding for 3 days. Moreover, both patients with gout (Br0chner-Mortensen, 1958 ) and patients with maturity-onset diabetes mellitus tend to be overweight, and the findings of some workers of an association between these diseases may simply reflect this fact. In epidemiological studies of Polynesian people, Prior and his associates (Prior and Davidson, 1966; Prior, Rose, Harvey, and Davidson, 1966) have described an increased prevalence of hyperuricaemia, gout, and diabetes mellitus of the maturity-onset type in overweight New Zealand Maoris.
Our data therefore suggest that gouty patients are to be compared with respect to the prevalence of diabetes mellitus and their carbohydrate and insulin metabolism with weight-matched control subjects. In only one study to our knowledge has such a comparison been made; Weiss, Segaloff, and Moore (1957) studied 143 gouty patients and compared their carbohydrate metabolism with 143 age and weight-matched controls. They found that forty of their patients with gout and 27 of their controls had an abnormal oral glucose tolerance test. On this basis they concluded that "the relationship between gout and elevated blood sugar appears to be more than a casual one". We do not feel that their data support their conclusion, since there is no significant difference between these results by a x2 analysis (X2 = 3-294; 0 1 <P < 0 2).
A surprising incidental finding was that the fasting plasma insulin values of the overweight control subjects was not higher than that of the lean controls.
Previous work (Bagdade, Bierman, and Porte, 1967) indicates that the fasting plasma insulin levels in obesity are higher than those in lean subjects. However, our overweight subjects did 
